Is Genomic Risk Stratification useful for Patients with early HR+/ERBB2 Breast Cancer?

被引：0
|
作者：
Lichert, Frank
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：474 / 474
页数：1
相关论文
共 50 条
  • [11] Genomic alterations in ERBB2 define a subset of pleomorphic invasive lobular breast cancer
    Hirshfield, Kim M.
    Sanders, Renee
    Feld, Heather K.
    Barnard, Nicola
    Liang, Li
    Zhong, Hua
    Bhanot, Gyan
    Sahota, Amrik S.
    Brooks, Andrew
    Rodriguez-Rodriguez, Lorna
    Ganesan, Shridar
    CANCER RESEARCH, 2015, 75
  • [12] Comprehensive genomic profiling of advanced HR+/HER2-breast cancer patients using liquid biopsy
    Shao, B.
    Tang, H.
    Liu, X-R.
    Song, G.
    Di, L.
    Xie, F.
    Jia, C.
    Zhang, Y.
    Jia, S.
    Li, H.
    ANNALS OF ONCOLOGY, 2023, 34 : S389 - S389
  • [13] Unique genomic and transcriptomic characteristics in young Chinese patients with HR+/HER2-invasive breast cancer
    Hu, Hong
    Hu, Zhenyu
    Liu, Ke
    Hu, Jintao
    Li, Fengyu
    Cao, Boyang
    Shao, Kang
    Shi, Wenzhao
    Feng, Gang
    Zhou, Wenbin
    CANCER RESEARCH, 2020, 80 (16)
  • [14] The prediction of Oncotype DX risk group using clinicopathologic factors in patients with HR+/HER2-early breast cancer
    Song, R.
    Lee, D. -E.
    Lee, S.
    Kang, H. -S.
    Han, J. H.
    Lee, K. S.
    Sim, S. H.
    Chae, H.
    Kwon, Y.
    Woo, J.
    Lee, M.
    Lee, E. -G.
    Jung, S. -Y.
    BREAST, 2023, 68 : S74 - S75
  • [15] A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2-early breast cancer
    Gong, Gyungyub
    Kwon, Mi Jeong
    Han, Jinil
    Lee, Hee Jin
    Lee, Se Kyung
    Lee, Jeong Eon
    Lee, Seon-Heui
    Park, Sarah
    Choi, Jong-Sun
    Cho, Soo Youn
    Ahn, Sei Hyun
    Lee, Jong Won
    Cho, Sang Rae
    Moon, Youngho
    Nam, Byung-Ho
    Nam, Seok Jin
    Choi, Yoon-La
    Shin, Young Kee
    SCIENTIFIC REPORTS, 2017, 7
  • [16] A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
    Gyungyub Gong
    Mi Jeong Kwon
    Jinil Han
    Hee Jin Lee
    Se Kyung Lee
    Jeong Eon Lee
    Seon-Heui Lee
    Sarah Park
    Jong-Sun Choi
    Soo Youn Cho
    Sei Hyun Ahn
    Jong Won Lee
    Sang Rae Cho
    Youngho Moon
    Byung-Ho Nam
    Seok Jin Nam
    Yoon-La Choi
    Young Kee Shin
    Scientific Reports, 7
  • [17] ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ
    Breyer, Johannes
    Otto, Wolfgang
    Wirtz, Ralph M.
    Wullich, Bernd
    Keck, Bastian
    Erben, Philipp
    Kriegmair, Maximilian C.
    Stoehr, Robert
    Eckstein, Markus
    Laible, Mark
    Schlombs, Kornelia
    Eidt, Sebastian
    Denzinger, Stefan
    Burger, Maximilian
    Hartmann, Arndt
    UROLOGIA INTERNATIONALIS, 2017, 98 (03) : 282 - 289
  • [18] Extending the benefits of adjuvant therapy in early HR+ breast cancer
    Paul E. Goss
    Breast Cancer Research and Treatment, 2008, 112 : 45 - 52
  • [19] Genomic and transcriptomic profiling of primary tumors from patients with HR+, HER2-, node-positive, high-risk early breast cancer in the monarchE trial
    Turner, Nicholas
    Reis-Filho, Jorge
    Goetz, Matthew
    Desmedt, Christine
    Chandarlapaty, Sarat
    Sasano, Hironobu
    Arteaga, Carlos
    Loi, Sherene
    Graff, Stephanie
    Liu, Deli
    Rodrik-Outmezguine, Vanessa
    Sireci, Anthony
    Rubenstein, Cynthia Sandoval
    Won, Helen
    Litchfield, Lacey M.
    Munoz, Maria
    Johnston, Stephen
    CANCER RESEARCH, 2024, 84 (09)
  • [20] Flotillins as regulators of ErbB2 levels in breast cancer
    Pust, S.
    Klokk, T. I.
    Musa, N.
    Jenstad, M.
    Risberg, B.
    Erikstein, B.
    Tcatchoff, L.
    Liestol, K.
    Danielsen, H. E.
    van Deurs, B.
    Sandvig, K.
    ONCOGENE, 2013, 32 (29) : 3443 - 3451
12345